Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 4724

1.

Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.

Hozumi K, Fukuoka H, Odake Y, Takeuchi T, Uehara T, Sato T, Inoshita N, Yoshida K, Matsumoto R, Bando H, Hirota Y, Iguchi G, Taniguchi M, Otsuki N, Nishigori C, Kosaki K, Hasegawa T, Ogawa W, Takahashi Y.

Endocr J. 2019 Jun 12. doi: 10.1507/endocrj.EJ19-0035. [Epub ahead of print]

PMID:
31189769
2.

CD151 confers metastatic potential to clear cell sarcoma of the soft tissue in animal model.

Kawashima K, Saigo C, Kito Y, Hanamatsu Y, Egawa Y, Takeuchi T.

Oncol Lett. 2019 Jun;17(6):4811-4818. doi: 10.3892/ol.2019.10164. Epub 2019 Mar 19.

3.

[Current status and problems of gastrointestinal bleeding induced by antithrombotic drugs including DOAC].

Harada S, Takeuchi T, Higuchi K.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(6):488-498. doi: 10.11405/nisshoshi.116.488. Japanese. No abstract available.

PMID:
31178578
4.

Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell.

Takeshita M, Suzuki K, Kondo Y, Morita R, Okuzono Y, Koga K, Kassai Y, Gamo K, Takiguchi M, Kurisu R, Mototani H, Ebisuno Y, Yoshimura A, Takeuchi T.

Ann Rheum Dis. 2019 Jun 5. pii: annrheumdis-2018-214885. doi: 10.1136/annrheumdis-2018-214885. [Epub ahead of print]

5.

Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor.

Iwai K, Nambu T, Dairiki R, Ohori M, Yu J, Burke K, Gotou M, Yamamoto Y, Ebara S, Shibata S, Hibino R, Nishizawa S, Miyazaki T, Homma M, Oguro Y, Imada T, Cho N, Uchiyama N, Kogame A, Takeuchi T, Kurasawa O, Yamanaka K, Niu H, Ohashi A.

Sci Adv. 2019 May 22;5(5):eaav3660. doi: 10.1126/sciadv.aav3660. eCollection 2019 May.

6.
7.

Smoking and pancreatic cancer incidence: a pooled analysis of ten population-based cohort studies in Japan.

Koyanagi YN, Ito H, Matsuo K, Sugawara Y, Hidaka A, Sawada N, Wada K, Nagata C, Tamakoshi A, Lin Y, Takeuchi T, Kitamura Y, Utada M, Sadakane A, Mizoue T, Naito M, Tanaka K, Shimazu T, Tsugane S, Inoue M.

Cancer Epidemiol Biomarkers Prev. 2019 May 21. pii: cebp.1327.2018. doi: 10.1158/1055-9965.EPI-18-1327. [Epub ahead of print]

PMID:
31113869
8.

The development of quality indicators for systemic lupus erythematosus using electronic health data: a modified RAND appropriateness method.

Yajima N, Tsujimoto Y, Fukuma S, Sada KE, Shimizu S, Niihata K, Takahashi R, Asano Y, Azuma T, Kameda H, Kuwana M, Kohsaka H, Sugiura-Ogasawara M, Suzuki K, Takeuchi T, Tanaka Y, Tamura N, Matsui T, Mimori T, Fukuhara S, Atsumi T.

Mod Rheumatol. 2019 May 21:1-15. doi: 10.1080/14397595.2019.1621419. [Epub ahead of print]

PMID:
31111758
9.

Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.

Kato M, Kaneko Y, Tanaka Y, Inoo M, Kobayashi-Haraoka H, Amano K, Miyata M, Murakawa Y, Yasuoka H, Hirata S, Nagasawa H, Tanaka E, Miyasaka N, Yamanaka H, Yamamoto K, Yokota I, Atsumi T, Takeuchi T.

Mod Rheumatol. 2019 Jun 7:1-8. doi: 10.1080/14397595.2019.1621026. [Epub ahead of print]

PMID:
31106666
10.

[Improvement of Fat Suppressing Effect for Finger and Neck MRI by Using Small Glass Beads].

Shiina R, Ogura A, Takeuchi T, Nakano H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(5):446-453. doi: 10.6009/jjrt.2019_JSRT_75.5.446. Japanese.

11.

Role of peptide transporter 2 and MAPK signaling pathways in the innate immune response induced by bacterial peptides in alveolar epithelial cells.

Takano M, Takeuchi T, Kuriyama S, Yumoto R.

Life Sci. 2019 Jul 15;229:173-179. doi: 10.1016/j.lfs.2019.05.042. Epub 2019 May 16.

PMID:
31103606
12.

Adaptation and visual discomfort from flicker.

Yoshimoto S, Jiang F, Takeuchi T, Wilkins AJ, Webster MA.

Vision Res. 2019 Jul;160:99-107. doi: 10.1016/j.visres.2019.04.010. Epub 2019 May 25.

PMID:
31091424
13.

Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study.

Ebina K, Hashimoto M, Yamamoto W, Hirano T, Hara R, Katayama M, Onishi A, Nagai K, Son Y, Amuro H, Yamamoto K, Maeda Y, Murata K, Jinno S, Takeuchi T, Hirao M, Kumanogoh A, Yoshikawa H.

PLoS One. 2019 May 8;14(5):e0216624. doi: 10.1371/journal.pone.0216624. eCollection 2019.

14.

Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.

Ebina K, Hashimoto M, Yamamoto W, Hirano T, Hara R, Katayama M, Onishi A, Nagai K, Son Y, Amuro H, Yamamoto K, Maeda Y, Murata K, Jinno S, Takeuchi T, Hirao M, Kumanogoh A, Yoshikawa H.

Arthritis Res Ther. 2019 May 6;21(1):114. doi: 10.1186/s13075-019-1897-8.

15.

Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.

Takeuchi T, Hongo H, Kimura T, Kojima Y, Harada S, Ota K, Takeuchi N, Noguchi T, Inoue T, Murano M, Higuchi K.

J Gastroenterol. 2019 Apr 29. doi: 10.1007/s00535-019-01588-4. [Epub ahead of print]

PMID:
31037449
16.

Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial.

Takeuchi T, Tanaka Y, Soen S, Yamanaka H, Yoneda T, Tanaka S, Nitta T, Okubo N, Genant HK, van der Heijde D.

Ann Rheum Dis. 2019 Jul;78(7):899-907. doi: 10.1136/annrheumdis-2018-214827. Epub 2019 Apr 29.

17.

Potential of biocompatible polymeric ultra-thin films, nanosheets, as topical and transdermal drug delivery devices.

Hatanaka T, Saito T, Fukushima T, Todo H, Sugibayashi K, Umehara S, Takeuchi T, Okamura Y.

Int J Pharm. 2019 Jun 30;565:41-49. doi: 10.1016/j.ijpharm.2019.04.059. Epub 2019 May 6.

PMID:
31022503
18.

Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.

Minashi K, Nihei K, Mizusawa J, Takizawa K, Yano T, Ezoe Y, Tsuchida T, Ono H, Iizuka T, Hanaoka N, Oda I, Morita Y, Tajika M, Fujiwara J, Yamamoto Y, Katada C, Hori S, Doyama H, Oyama T, Nebiki H, Amagai K, Kubota Y, Nishimura K, Kobayashi N, Suzuki T, Hirasawa K, Takeuchi T, Fukuda H, Muto M.

Gastroenterology. 2019 Apr 20. pii: S0016-5085(19)36710-1. doi: 10.1053/j.gastro.2019.04.017. [Epub ahead of print]

19.

A comprehensive reference transcriptome resource for the Iberian ribbed newt Pleurodeles waltl, an emerging model for developmental and regeneration biology.

Matsunami M, Suzuki M, Haramoto Y, Fukui A, Inoue T, Yamaguchi K, Uchiyama I, Mori K, Tashiro K, Ito Y, Takeuchi T, Suzuki KT, Agata K, Shigenobu S, Hayashi T.

DNA Res. 2019 Apr 22. pii: dsz003. doi: 10.1093/dnares/dsz003. [Epub ahead of print]

PMID:
31006799
21.

Site-specific post-imprinting modification of molecularly imprinted polymer nanocavities with a modifiable functional monomer for prostate cancer biomarker recognition.

Matsumoto H, Sunayama H, Kitayama Y, Takano E, Takeuchi T.

Sci Technol Adv Mater. 2019 Apr 1;20(1):305-312. doi: 10.1080/14686996.2019.1583495. eCollection 2019.

22.

Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats.

Yang F, Takeuchi T, Tsuneyama K, Yokoi T, Oda S.

Toxicol Sci. 2019 Apr 15. pii: kfz088. doi: 10.1093/toxsci/kfz088. [Epub ahead of print]

PMID:
30985903
23.

Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitis.

Tani H, Nagai K, Hosokawa T, Hata K, Kotani T, Ishida S, Takeuchi T, Arawaka S.

J Neurol. 2019 Apr 13. doi: 10.1007/s00415-019-09318-9. [Epub ahead of print]

PMID:
30982149
24.

Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.

Ebina K, Hashimoto M, Yamamoto W, Hirano T, Hara R, Katayama M, Onishi A, Nagai K, Son Y, Amuro H, Yamamoto K, Maeda Y, Murata K, Jinno S, Takeuchi T, Hirao M, Kumanogoh A, Yoshikawa H.

Arthritis Res Ther. 2019 Apr 11;21(1):91. doi: 10.1186/s13075-019-1880-4. Erratum in: Arthritis Res Ther. 2019 May 6;21(1):114.

25.

A Randomized Placebo-controlled Trial of an Oral Preparation of High Molecular Weight Fucoidan in Patients with Type 2 Diabetes with Evaluation of Taste Sensitivity.

Sakai C, Abe S, Kouzuki M, Shimohiro H, Ota Y, Sakinada H, Takeuchi T, Okura T, Kasagi T, Hanaki K.

Yonago Acta Med. 2019 Mar 28;62(1):14-23. eCollection 2019 Mar.

26.
27.

Occupational class differences in pancreatic cancer survival: A population-based cancer registry-based study in Japan.

Zaitsu M, Kim Y, Lee HE, Takeuchi T, Kobayashi Y, Kawachi I.

Cancer Med. 2019 Jun;8(6):3261-3268. doi: 10.1002/cam4.2138. Epub 2019 Apr 5.

28.

Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders.

Tokuhira M, Saito S, Suzuki K, Higashi M, Momose S, Shimizu T, Mori T, Kimura Y, Amano K, Okamoto S, Takeuchi T, Tamaru JI, Kizaki M.

Leuk Lymphoma. 2019 Apr 5:1-8. doi: 10.1080/10428194.2019.1585841. [Epub ahead of print]

PMID:
30947579
29.

Effect of spatial attention on spatiotopic visual motion perception.

Yoshimoto S, Takeuchi T.

J Vis. 2019 Apr 1;19(4):4. doi: 10.1167/19.4.4.

PMID:
30943532
30.

CREG1 stimulates brown adipocyte formation and ameliorates diet-induced obesity in mice.

Hashimoto M, Kusudo T, Takeuchi T, Kataoka N, Mukai T, Yamashita H.

FASEB J. 2019 Mar 27:fj201802147RR. doi: 10.1096/fj.201802147RR. [Epub ahead of print]

PMID:
30917000
31.

Detachable glass micro/nanofluidic device.

Ohta R, Mawatari K, Takeuchi T, Morikawa K, Kitamori T.

Biomicrofluidics. 2019 Mar 14;13(2):024104. doi: 10.1063/1.5087003. eCollection 2019 Mar.

PMID:
30915180
32.

Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.

Hayami H, Takahashi S, Ishikawa K, Yasuda M, Yamamoto S, Wada K, Kobayashi K, Hamasuna R, Minamitani S, Matsumoto T, Kiyota H, Tateda K, Sato J, Hanaki H, Masumori N, Nishiyama H, Miyazaki J, Fujimoto K, Tanaka K, Uehara S, Matsubara A, Ito K, Hayashi K, Kurimura Y, Ito S, Takeuchi T, Narita H, Izumitani M, Nishimura H, Kawahara M, Hara M, Hosobe T, Takashima K, Chokyu H, Matsumura M, Ihara H, Uno S, Monden K, Sumii T, Kawai S, Kariya S, Sato T, Yoshioka M, Kadena H, Matsushita S, Nishi S, Hosokawa Y, Shirane T, Yoh M, Watanabe S, Makinose S, Uemura T, Goto H.

J Infect Chemother. 2019 Jun;25(6):413-422. doi: 10.1016/j.jiac.2019.02.021. Epub 2019 Mar 21.

33.

Response to Yang et. al.

Asano Y, Saigo C, Kito Y, Iwata Y, Yoshida K, Takeuchi T.

J Mol Med (Berl). 2019 May;97(5):739-740. doi: 10.1007/s00109-019-01775-z. Epub 2019 Mar 23. No abstract available.

PMID:
30903230
34.

Oligoarginine-Bearing Tandem Repeat Penetration-Accelerating Sequence Delivers Protein to Cytosol via Caveolae-Mediated Endocytosis.

Okuda A, Tahara S, Hirose H, Takeuchi T, Nakase I, Ono A, Takehashi M, Tanaka S, Futaki S.

Biomacromolecules. 2019 May 13;20(5):1849-1859. doi: 10.1021/acs.biomac.8b01299. Epub 2019 Apr 1.

PMID:
30893557
35.

Spatially Arranged Sparse Recurrent Neural Networks for Energy Efficient Associative Memory.

Tanaka G, Nakane R, Takeuchi T, Yamane T, Nakano D, Katayama Y, Hirose A.

IEEE Trans Neural Netw Learn Syst. 2019 Mar 15. doi: 10.1109/TNNLS.2019.2899344. [Epub ahead of print]

PMID:
30892239
36.

Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review.

Miyazaki H, Igarashi A, Takeuchi T, Teng L, Uda A, Deguchi H, Higuchi K, Tango T.

J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1111/jgh.14664. [Epub ahead of print]

PMID:
30883868
37.

Galectin-2 suppresses nematode development by binding to the invertebrate-specific galactoseβ1-4fucose glyco-epitope.

Takeuchi T, Tamura M, Ishiwata K, Hamasaki M, Hamano S, Arata Y, Hatanaka T.

Glycobiology. 2019 Jun 1;29(6):504-512. doi: 10.1093/glycob/cwz022.

PMID:
30874734
38.

Characterization and Biodistribution Analysis of Oxygen-Doped Single-Walled Carbon Nanotubes Used as in Vivo Fluorescence Imaging Probes.

Takeuchi T, Iizumi Y, Yudasaka M, Kizaka-Kondoh S, Okazaki T.

Bioconjug Chem. 2019 May 15;30(5):1323-1330. doi: 10.1021/acs.bioconjchem.9b00088. Epub 2019 Mar 20.

PMID:
30848886
39.

Occupational Class and Risk of Cardiovascular Disease Incidence in Japan: Nationwide, Multicenter, Hospital-Based Case-Control Study.

Zaitsu M, Kato S, Kim Y, Takeuchi T, Sato Y, Kobayashi Y, Kawachi I.

J Am Heart Assoc. 2019 Mar 19;8(6):e011350. doi: 10.1161/JAHA.118.011350.

40.

Concise Synthesis of Potassium Acyltrifluoroborates from Aldehydes through Copper(I)-Catalyzed Borylation/Oxidation.

Taguchi J, Takeuchi T, Takahashi R, Masero F, Ito H.

Angew Chem Int Ed Engl. 2019 May 27;58(22):7299-7303. doi: 10.1002/anie.201901748. Epub 2019 Mar 26.

PMID:
30844125
41.

Radiographic and clinical outcomes following etanercept monotherapy in Japanese methotrexate-naïve patients with active rheumatoid arthritis.

Takeuchi T, Miyasaka N, Pedersen R, Sugiyama N, Hirose T.

Mod Rheumatol. 2019 Mar 6:1-10. doi: 10.1080/14397595.2019.1589918. [Epub ahead of print]

PMID:
30836801
42.

Pulmonary Vein Vasculitis Presenting as Multiple Pulmonary Nodules in a Patient with Systemic Lupus Erythematosus.

Tamai H, Nishina N, Takeuchi T.

J Rheumatol. 2019 Mar;46(3):323-324. doi: 10.3899/jrheum.180602. No abstract available.

PMID:
30824668
43.

Characterization of very long chain fatty acid synthesis inhibition by ipfencarbazone.

Kasahara T, Matsumoto H, Hasegawa H, Koyama K, Takeuchi T.

J Pestic Sci. 2019 Feb 20;44(1):20-24. doi: 10.1584/jpestics.D18-057.

44.

Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study.

Tanaka Y, Takeuchi T, Okada M, Ishii T, Nakajima H, Kawai S, Nagashima T, Hayashi N, Wang L, Tummala R.

Mod Rheumatol. 2019 Feb 22:1-8. doi: 10.1080/14397595.2019.1583833. [Epub ahead of print]

PMID:
30793642
45.

Does microbiome contribute to HLA-B52-positive Takayasu arteritis?

Akiyama M, Kaneko Y, Takeuchi T.

Mod Rheumatol. 2019 Mar 21:1-5. doi: 10.1080/14397595.2019.1584146. [Epub ahead of print] No abstract available. Erratum in: Mod Rheumatol. 2019 May 7;:1.

PMID:
30793628
46.

Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study.

Takeuchi T, Tanaka Y, Matsumura R, Saito K, Yoshimura M, Amano K, Atsumi T, Suematsu E, Hayashi N, Wang L, Tummala R.

Mod Rheumatol. 2019 Feb 21:1-8. doi: 10.1080/14397595.2019.1583832. [Epub ahead of print]

PMID:
30791804
47.

Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials.

Harigai M, Takeuchi T, Smolen JS, Winthrop KL, Nishikawa A, Rooney TP, Saifan CG, Issa M, Isaka Y, Akashi N, Ishii T, Tanaka Y.

Mod Rheumatol. 2019 Feb 20:1-8. doi: 10.1080/14397595.2019.1583711. [Epub ahead of print]

PMID:
30784354
48.

Corrigendum to "Single-center experience with percutaneous lead extraction of cardiac implantable electric devices" [J. Cardiol. 71 (2018) 192-196].

Okada A, Shoda M, Tabata H, Shoin W, Kobayashi H, Okano T, Yoshie K, Oguchi Y, Takeuchi T, Kato K, Kuwahara K.

J Cardiol. 2019 Mar;73(3):262. doi: 10.1016/j.jjcc.2018.12.001. No abstract available.

PMID:
30770038
49.

Treatment of intrabony periodontal defects using rhFGF-2 in combination with deproteinized bovine bone mineral or rhFGF-2 alone: A 6-month randomized controlled trial.

Saito A, Bizenjima T, Takeuchi T, Suzuki E, Sato M, Yoshikawa K, Kitamura Y, Matsugami D, Aoki H, Kita D, Imamura K, Irokawa D, Seshima F, Tomita S.

J Clin Periodontol. 2019 Mar;46(3):332-341. doi: 10.1111/jcpe.13086.

PMID:
30758076
50.

Fluoropyrimidine-induced intestinal mucosal injury is associated with the severity of chemotherapy-related diarrhea.

Ota K, Takeuchi T, Kojima Y, Harada S, Ozaki H, Sugawara N, Hirata Y, Yamaguchi T, Terazawa T, Kakimoto K, Kii T, Goto M, Higuchi K.

Scand J Gastroenterol. 2019 Feb;54(2):227-232. doi: 10.1080/00365521.2019.1575466. Epub 2019 Feb 10.

PMID:
30739515

Supplemental Content

Loading ...
Support Center